Novartis Ag (NVS) Revenue (2009 - 2026)
Novartis Ag's Revenue came in at $14.41 billion for Q2 2026, up 2.5% from $14.05 billion a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Revenue (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Revenue of $52.41 billion, up 2.9% year-over-year; for FY2025, it came in at $54.53 billion, up 8.4% from FY2024.
- Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- Going back by year, Revenue was $50.32 billion in FY2024 (+10.7%), $45.44 billion in FY2023 (+7.7%), $42.21 billion in FY2022 (-1.3%) and $42.78 billion in FY2021 (-12.1%).
- The Q2 2026 figure represents the highest quarterly Revenue since Q4 2013.
- The fastest year-over-year change in Revenue over five years came in Q2 2025 (growth of 12.3%), and the weakest in Q2 2023 (a decline of 10.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 14.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.41 Bn |
| Mar 31, 2026 | 13.11 Bn |
| Dec 31, 2025 | 13.34 Bn |
| Sep 30, 2025 | 13.91 Bn |
| Jun 30, 2025 | 14.05 Bn |
| Mar 31, 2025 | 13.23 Bn |
| Dec 31, 2024 | 13.15 Bn |
| Sep 30, 2024 | 12.82 Bn |
| Jun 30, 2024 | 12.51 Bn |
| Mar 31, 2024 | 11.83 Bn |
| Dec 31, 2023 | 11.42 Bn |
| Sep 30, 2023 | 11.78 Bn |
| Jun 30, 2023 | 11.44 Bn |
| Mar 31, 2023 | 10.80 Bn |
| Dec 31, 2022 | 10.58 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 12.78 Bn |
| Mar 31, 2022 | 12.53 Bn |
| Dec 31, 2021 | 13.23 Bn |
| Sep 30, 2021 | 13.03 Bn |
API Access
Novartis Ag Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();